Pacritinib
Pacritinib, sold under the brand name Vonjo, is an anti-cancer medication used to treat myelofibrosis.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Pacritinib, sold under the brand name Vonjo, is an anti-cancer medication used to treat myelofibrosis. It is a macrocyclic protein kinase inhibitor. It mainly inhibits Janus kinase 2 (JAK2) and Fms-like tyrosine kinase 3\CD135 (FLT3). Common side effects include diarrhea, low platelet counts, nausea, anemia, and swelling in legs.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1377170292 under CC BY-SA 4.0; modifications have been made.